期刊
JOURNAL OF LIPID RESEARCH
卷 50, 期 11, 页码 2299-2305出版社
ELSEVIER
DOI: 10.1194/jlr.M900122-JLR200
关键词
ATP binding cassette transporter A1; high density lipoprotein; atherosclerosis; calpain; probucol
资金
- Ministry of Education, Culture, Science, Sports and Technology of Japan
- Japan Health Science Foundation
- National Institute of Biomedical Innovation
- Grants-in-Aid for Scientific Research [21591164, 21390188] Funding Source: KAKEN
Expression of ABCA1 is regulated by transcription of the gene and calpain-mediated proteolytic degradation, and inhibition ABCA1 degradation results in increased ABCA1 and HDL biogenesis in vitro. We examined whether this approach could be a potential antiatherogenic treatment. Although probucol inhibits both the activity and degradation of ABCA1, its oxidized products, spiroquinone and diphenoquinone, reduce degradation of ABCA1 without inhibiting its activity or altering transcription of the ABCA1 gene. Accordingly, both compounds enhanced apolipoprotein A-I/ABCA1-dependent generation of HDL in vitro, and increased hepatic ABCA1 and plasma HDL without increasing antioxidant activity in plasma when given to rabbits. Both compounds also decreased vascular lipid deposition in cholesterol-fed rabbits. We therefore conclude that stabilization of ABCA1 against calpain-mediated degradation is a novel and potentially important strategy to increase HDL formation and prevent atherosclerosis. Spiroquinone and diphenoquinone are potential seeds for development of such drugs.-Arakawa, R., M. Tsujita, N. Iwamoto, C. Ito-Ohsumi, R. Lu, C-A. Wu, K. Shimizu, T. Aotsuka, H. Kanazawa, S. Abe-Dohmae, and S. Yokoyama. Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis. J. Lipid Res. 2009. 50: 2299-2305.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据